Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126930472 | 12693047 | 2 | F | 20160817 | 20160829 | 20160830 | EXP | AU-APOTEX-2016AP010709 | APOTEX | BOYD I.. THIAMAZOLE AND RHABDOMYOLYSIS.. WHO-PHARM-NEWS. 2016;4:17-23 | 33.00 | YR | M | Y | 0.00000 | 20160830 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126930472 | 12693047 | 1 | SS | CHEMMART ALPRAZOLAM | ALPRAZOLAM | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 126930472 | 12693047 | 2 | SS | APO-BISOPROLOL | BISOPROLOL FUMARATE | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 126930472 | 12693047 | 3 | PS | APO-CANDESARTAN | CANDESARTAN | 1 | Unknown | UNK | U | U | 202079 | TABLET | |||||||
| 126930472 | 12693047 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 126930472 | 12693047 | 5 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNK | U | U | 0 | CAPSULE | |||||||
| 126930472 | 12693047 | 6 | SS | WARFARIN APOTEX | WARFARIN | 1 | Unknown | U | U | 0 | TABLET | ||||||||
| 126930472 | 12693047 | 7 | SS | THIAMAZOLE | METHIMAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 126930472 | 12693047 | 8 | SS | PROPYLTHIOURACIL. | PROPYLTHIOURACIL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126930472 | 12693047 | 9 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126930472 | 12693047 | 1 | Product used for unknown indication |
| 126930472 | 12693047 | 2 | Product used for unknown indication |
| 126930472 | 12693047 | 3 | Product used for unknown indication |
| 126930472 | 12693047 | 4 | Product used for unknown indication |
| 126930472 | 12693047 | 5 | Product used for unknown indication |
| 126930472 | 12693047 | 6 | Product used for unknown indication |
| 126930472 | 12693047 | 7 | Product used for unknown indication |
| 126930472 | 12693047 | 8 | Product used for unknown indication |
| 126930472 | 12693047 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126930472 | 12693047 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126930472 | 12693047 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |